Identification of NF-kappaB responsive elements in follistatin related gene (FLRG) promoter

Gene

Volumn 393, Issue 1-2, 2007, Pages 153-162

  Bartholin, Laurent ^a,b,c   Guindon, Stéphane ^d   Martel, Sylvie ^a,b,c   Corbo, Laura ^a,b,c   Rimokh, Ruth ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE LYON   (France)

^c CENTRE LÉON BÉRARD   (France)

^d LIRMM   (France)

Author keywords

FLRG; FSTL3; Leukemia; NF kappaB; Smad; TGF beta

Indexed keywords

ACTIVIN A; FOLLISTATIN RELATED PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOSTATIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; EVOLUTION, MOLECULAR; FOLLISTATIN-RELATED PROTEINS; HUMANS; MINK; MOLECULAR SEQUENCE DATA; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROTEIN BINDING; RESPONSE ELEMENTS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

PRIMATES;

EID: 34147099074     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2007.02.007     Document Type: Article

References (34)

1. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3 (2003) 745-756
2. Altschul S.F., Gish W., Miller W., Myers E.W., and Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215 (1990) 403-410
3. Azoitei N., Wirth T., and Baumann B. Activation of the IkappaB kinase complex is sufficient for neuronal differentiation of PC12 cells. J. Neurochem. 93 (2005) 1487-1501
4. Bartholin L., Destaing O., Forissier S., Martel S., Maguer-Satta V., Jurdic P., and Rimokh R. FLRG, a new ADAM12-associated protein, modulates osteoclast differentiation. Biol. Cell 97 (2005) 577-588
5. Bartholin L., Maguer-Satta V., Hayette S., Martel S., Gadoux M., Bertrand S., Corbo L., Lamadon C., Morera A.M., Magaud J.P., and Rimokh R. FLRG, an activin-binding protein, is a new target of TGFbeta transcription activation through Smad proteins. Oncogene 20 (2001) 5409-5419
6. Bartholin L., Maguer-Satta V., Hayette S., Martel S., Gadoux M., Corbo L., Magaud J.P., and Rimokh R. Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function. Oncogene 21 (2002) 2227-2235
7. Braun T., Carvalho G., Fabre C., Grosjean J., Fenaux P., and Kroemer G. Targeting NF-kappaB in hematologic malignancies. Cell Death Differ. 13 (2006) 748-758
8. Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., and Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. U. S. A. 72 (1975) 3666-3670
9. Ciarmela P., Florio P., Toti P., Franchini A., Maguer-Satta V., Ginanneschi C., Ottaviani E., and Petraglia F. Human placenta and fetal membranes express follistatin-related gene mRNA and protein. J. Endocrinol. Investig. 26 (2003) 641-645
10. Cuni S., Perez-Aciego P., Perez-Chacon G., Vargas J.A., Sanchez A., Martin-Saavedra F.M., Ballester S., Garcia-Marco J., Jorda J., and Durantez A. A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia 18 (2004) 1391-1400
11. Dennler S., Itoh S., Vivien D., Ten Dijke P., Huet S., and Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17 (1998) 3091-3100
12. Furman R.R., Asgary Z., Mascarenhas J.O., Liou H.C., and Schattner E.J. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells. J. Immunol. 164 (2000) 2200-2206
13. Green S., Dobrjansky A., Carswell E.A., Kassel R.L., Old L.J., Fiore N., and Schwartz M.K. Partial purification of a serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. U. S. A. 73 (1976) 381-385
14. Guindon S., and Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 52 (2003) 696-704
15. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev. 18 (2004) 2195-2224
16. Hayette S., Gadoux M., Martel S., Bertrand S., Tigaud I., Magaud J.P., and Rimokh R. FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene 16 (1998) 2949-2954
17. Hill J.J., Davies M.V., Pearson A.A., Wang J.H., Hewick R.M., Wolfman N.M., and Qiu Y. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J. Biol. Chem. 277 (2002) 40735-40741
18. Hou B., Eren M., Painter C.A., Covington J.W., Dixon J.D., Schoenhard J.A., and Vaughan D.E. Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site. J. Biol. Chem. 279 (2004) 18127-18136
19. Huelsenbeck J.P., and Ronquist F. MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17 (2001) 754-755
20. Kon A., Vindevoghel L., Kouba D.J., Fujimura Y., Uitto J., and Mauviel A. Cooperation between SMAD and NF-kappaB in growth factor regulated type VII collagen gene expression. Oncogene 18 (1999) 1837-1844
21. MacEwan D.J. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal. 14 (2002) 477-492
22. Maguer-Satta V., Bartholin L., Jeanpierre S., Ffrench M., Martel S., Magaud J.P., and Rimokh R. Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGFbeta family. Exp. Cell Res. 282 (2003) 110-120
23. Maguer-Satta V., Bartholin L., Jeanpierre S., Gadoux M., Bertrand S., Martel S., Magaud J.P., and Rimokh R. Expression of FLRG, a novel activin A ligand, is regulated by TGF-beta and during hematopoiesis [corrected]. Exp. Hematol 29 (2001) 301-308
24. Maguer-Satta V., Forissier S., Bartholin L., Martel S., Jeanpierre S., Bachelard E., and Rimokh R. A novel role for fibronectin type I domain in the regulation of human hematopoietic cell adhesiveness through binding to follistatin domains of FLRG and follistatin. Exp. Cell Res. 312 (2006) 434-442
25. Maguer-Satta V., and Rimokh R. FLRG, member of the follistatin family, a new player in hematopoiesis. Mol. Cell Endocrinol 225 (2004) 109-118
26. Schmitz M.L., Bacher S., and Kracht M. I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations. Trends Biochem. Sci. 26 (2001) 186-190
27. Sen R., and Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47 (1986) 921-928
28. Sen R., and Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46 (1986) 705-716
29. Sidis Y., Mukherjee A., Keutmann H., Delbaere A., Sadatsuki M., and Schneyer A. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology 147 (2006) 3586-3597
30. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 (1994) 4673-4680
31. Tsuchida K., Arai K.Y., Kuramoto Y., Yamakawa N., Hasegawa Y., and Sugino H. Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J. Biol. Chem. 275 (2000) 40788-40796
32. Verrecchia F., and Mauviel A. TGF-beta and TNF-alpha: antagonistic cytokines controlling type I collagen gene expression. Cell Signal 16 (2004) 873-880
33. Xia Y., Sidis Y., and Schneyer A. Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice. Mol. Endocrinol 18 (2004) 979-994
34. Zipori D., and Barda-Saad M. Role of activin A in negative regulation of normal and tumor B lymphocytes. J. Leukoc. Biol. 69 (2001) 867-873